We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current ATHA market cap is 126.87M. The company's latest EPS is USD -3.0701 and P/E is -1.07.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 1.63M | 0 |
| Operating Income | -29.77M | -31.64M | -35.04M | -29.01M | -27.69M |
| Net Income | -27.82M | -29.6M | -32.97M | -27.29M | -26.34M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 1.63M |
| Operating Income | -5.45M | -20M | -64.02M | -104.02M | -125.47M |
| Net Income | -5.16M | -19.96M | -54.85M | -95.64M | -117.67M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 232.77M | 208.05M | 184.7M | 160.25M | 133.46M |
| Total Liabilities | 21.65M | 23.07M | 29.94M | 30.06M | 26.72M |
| Total Equity | 211.13M | 184.98M | 154.76M | 130.19M | 106.74M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 2.19M | 279.56M | 332.01M | 258.15M | 160.25M |
| Total Liabilities | 4.86M | 5.28M | 10.92M | 23.02M | 30.06M |
| Total Equity | -19.72M | 274.28M | 321.08M | 235.14M | 130.19M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -26.19M | -50.48M | -74.46M | -100.75M | -25.8M |
| Investing | 35.52M | 68.01M | 88.7M | 95.09M | 13.04M |
| Financing | 99k | 341k | 341k | 493k | N/A |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -3.71M | -24.11M | -43.1M | -72.47M | -100.75M |
| Investing | 1.51M | -210.07M | -4.08M | 57.66M | 95.09M |
| Financing | 946k | 292.75M | 97.09M | 654k | 493k |
| Market Cap | 126.87M |
| Price to Earnings Ratio | -1.07 |
| Price to Sales Ratio | 77.65 |
| Price to Cash Ratio | 1.4 |
| Price to Book Ratio | 0.97 |
| Dividend Yield | - |
| Shares Outstanding | 38.33M |
| Average Volume (1 week) | 80.04k |
| Average Volume (1 Month) | 140.71k |
| 52 Week Change | 19.93% |
| 52 Week High | 4.2984 |
| 52 Week Low | 1.33 |
| Spread (Intraday) | 0.58 (15.98%) |
| Company Name | Athira Pharma Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.athira.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
